N-methyl-D-aspartate receptors mediate endogenous opioid release in enteric neurons after abdominal surgery

Simona Patierno1, Wubanche Zellalem, Anthony Ho

  • 1CURE Digestive Diseases Research Center, Digestive Diseases Division, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, 90073, USA. kira@ucla.edu

Gastroenterology
|June 9, 2005
PubMed
Abstract

Insights

Surgery triggers local glutamate release, activating peripheral N-methyl-D-aspartate (NMDA) receptors to cause endogenous opioid release in enteric neurons. This highlights the interplay between glutamatergic and opioid systems during surgical stimulation.

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Pharmacology

Background:

  • Surgery can induce opioid release in enteric neurons.
  • N-methyl-D-aspartate (NMDA) receptors are hypothesized to mediate this release.

Purpose of the Study:

  • To test if NMDA receptors mediate surgery-induced opioid release in enteric neurons.
  • To investigate the interaction between glutamatergic and opioid systems in response to surgical stimuli.

Main Methods:

  • Mu opioid receptor (muOR) internalization was used to measure opioid release via immunohistochemistry and confocal microscopy.
  • Guinea pig ileal segments were subjected to abdominal laparotomy with and without NMDA-receptor antagonists (MK-801, AP-5) or AMPA-receptor antagonists (MRZ 2/576, MRZ 2/596).
  • Enteric neurons were also exposed to NMDA or electrical stimulation with or without NMDA-receptor antagonists.

Main Results:

  • Abdominal laparotomy-induced muOR endocytosis was significantly inhibited by NMDA-receptor antagonists in both nondenervated and denervated ileal segments.
  • AMPA-receptor antagonists did not inhibit muOR endocytosis.
  • NMDA or electrical stimulation-induced muOR endocytosis was prevented by NMDA-receptor antagonists.

Conclusions:

  • Abdominal laparotomy leads to local glutamate release, activating peripheral NMDA receptors and causing endogenous opioid release.
  • This study suggests a significant interaction between the glutamatergic and opioid systems in response to surgical stimulation.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...